A literature review of biosensors for multiple sclerosis: Towards personalized medicine and point-of-care testing

被引:9
作者
Demirdogen, Birsen Can [1 ]
机构
[1] TOBB Univ Econ & Technol, Dept Biomed Engn, Ankara, Turkey
关键词
Biomarker; Immunosensor; Lab-on-a-chip; Microfluidic; Nanomaterial; Nanoparticle; Point-of-care testing; Patient-centered healthcare; Personalized medicine; MYELIN BASIC-PROTEIN; EPSTEIN-BARR-VIRUS; SURFACE-PLASMON RESONANCE; CEREBROSPINAL-FLUID; TAU-PROTEIN; OLIGODENDROCYTE GLYCOPROTEIN; ANTIBODY DETECTION; SERUM-LEVELS; BIOMARKERS; MMP-9;
D O I
10.1016/j.msard.2020.102675
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Multiple sclerosis (MS) is a chronic neuroinflammatory disease of the central nervous system that leads to severe motor and sensory deficits in patients. Although some biomolecules in serum or cerebrospinal fluid have been suggested as biomarkers for MS diagnosis, following disease activity and monitoring treatment response, most of these potential biomarkers are not currently in clinical use and available for all patients. The reasons behind this are generally related to insufficient robustness of biomarker or technical difficulties, high prices, and requirements for technical personnel for their detection. Point-of-care testing (POCT) is an emerging field of healthcare that can be applied at the hospital as well as at home without the need for a centralized laboratory. Biosensor devices offer a convenient means for POCT. A biosensor is a compact analytical device that uses a bioreceptor, such as an antibody, enzyme, or oligonucleotide, to capture the analyte of interest. The interaction between the analyte and the bioreceptor is sensed and transduced into a suitable signal by the signal transducer. The advantages of using a biosensor for detecting the biomolecule of interest include speed, simplicity, accuracy, relatively lower cost, and lack of requirements for highly qualified personnel to perform the testing. Owing to these advantages and with the help of innovations in biosensor development technologies, there has been a great interest in developing biosensor devices for MS in recent years. Hence, the purpose of this review was to provide researchers with an up-to-date summary of the literature as well as to highlight the challenges and opportunities in this translational research field. In addition, because this is a highly interdisciplinary field of study, potentially concerning MS specialists, neurologists, biomedical researchers, and engineers, another aim of this review was to bridge the gap between these disciplines.
引用
收藏
页数:11
相关论文
共 100 条
  • [1] Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework
    Atkinson, AJ
    Colburn, WA
    DeGruttola, VG
    DeMets, DL
    Downing, GJ
    Hoth, DF
    Oates, JA
    Peck, CC
    Schooley, RT
    Spilker, BA
    Woodcock, J
    Zeger, SL
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (03) : 89 - 95
  • [2] Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes
    Avolio, C
    Ruggieri, M
    Giuliani, F
    Liuzzi, GM
    Leante, R
    Riccio, P
    Livrea, P
    Trojano, M
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2003, 136 (1-2) : 46 - 53
  • [3] Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues
    Bandres, E.
    Cubedo, E.
    Agirre, X.
    Malumbres, R.
    Zarate, R.
    Ramirez, N.
    Abajo, A.
    Navarro, A.
    Moreno, I.
    Monzo, M.
    Garcia-Foncillas, J.
    [J]. MOLECULAR CANCER, 2006, 5 (1)
  • [4] Interactions between Human Antibodies and Synthetic Conformational Peptide Epitopes: Innovative Approach for Electrochemical Detection of Biomarkers of Multiple Sclerosis at Platinum Electrodes
    Bellagha-Chenchah, W.
    Sella, C.
    Real Fernandez, F.
    Peroni, E.
    Lolli, F.
    Amatore, C.
    Thouin, L.
    Papini, A. M.
    [J]. ELECTROCHIMICA ACTA, 2015, 176 : 1239 - 1247
  • [5] Matrix metalloproteinase-9 and matrix metalloproteinase-2 as biomarkers of various courses in multiple sclerosis
    Benesova, Y.
    Vasku, A.
    Novotna, H.
    Litzman, J.
    Stourac, P.
    Beranek, M.
    Kadanka, Z.
    Bednarik, J.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2009, 15 (03) : 316 - 322
  • [6] A cytokine immunosensor for Multiple Sclerosis detection based upon label-free electrochemical impedance spectroscopy using electroplated printed circuit board electrodes
    Bhavsar, Kinjal
    Fairchild, Aaron
    Alonas, Eric
    Bishop, Daniel K.
    La Belle, Jeffrey T.
    Sweeney, James
    Alford, T. L.
    Joshi, Lokesh
    [J]. BIOSENSORS & BIOELECTRONICS, 2009, 25 (02) : 506 - 509
  • [7] Disposable MMP-9 sensor based on the degradation of peptide cross-linked hydrogel films using electrochemical impedance spectroscopy
    Biela, Anna
    Watkinson, Michael
    Meier, Ute C.
    Baker, David
    Giovannoni, Gavin
    Becer, C. Remzi
    Krause, Steffi
    [J]. BIOSENSORS & BIOELECTRONICS, 2015, 68 : 660 - 667
  • [8] Myelin basic protein: a multifunctional protein
    Boggs, J. M.
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2006, 63 (17) : 1945 - 1961
  • [9] Diagnosis of multiple sclerosis: progress and challenges
    Brownlee, Wallace J.
    Hardy, Todd A.
    Fazekas, Franz
    Miller, David H.
    [J]. LANCET, 2017, 389 (10076) : 1336 - 1346
  • [10] Christensen T, 2007, Int MS J, V14, P41